HRTX Heron Therapeutics Inc.

17.18
+0.28  (+2%)
Previous Close 16.9
Open 16.99
Price To Book 4.49
Market Cap 1,371,246,044
Shares 79,816,417
Volume 696,227
Short Ratio
Av. Daily Volume 792,371

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL announced May 1, 2019.
HTX-011
Post operative pain
CRL Mar 28 2013. Approved August 10 2016.
APF530 - Sustol
Prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV)
FDA additional approval allowing IV injection in addition to current IV infusion.
CINVANTI (HTX-019)
Prevention of chemotherapy-induced nausea and vomiting (CINV)
Phase 2 data released June 21, 2018. Primary endpoint met.
HTX-011
Total knee arthroplasty

Latest News

  1. Biotech Stocks to Watch Through the 2nd Half of 2019
  2. FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, EGBN and CARB
  3. Final Deadline:(HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019
  4. Is Heron Therapeutics (NASDAQ:HRTX) Using Debt Sensibly?
  5. SHAREHOLDER ALERT: HRTX RBGLY JE: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  6. Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
  7. Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Updates
  8. MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  9. CLASS ACTION UPDATE for HRTX, EROS and MNK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  10. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, STG, PVTL and GTT
  11. Pawar Law Group Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
  12. The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, RLGY and NFLX
  13. LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
  14. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, PVTL and INS
  15. SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – HRTX
  16. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, PVTL and RBGLY
  17. Approaching Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019
  18. The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, NFLX and LB